Fact.MR – A Market Research and Competitive Intelligence Provider: Over the forecast period, the global antibacterial drugs market is expected to grow at a CAGR of 2.6%, reaching a valuation of over US$ 62 billion by 2031 and surpassing US$ 51 billion by 2025.
Antibacterial Drugs Market to Attain US$ 62 Billion by 2031: Fact.MR Study
The Fact.MR market study provides a comprehensive analysis of the antibacterial drugs market, highlighting key trends and strategies adopted by leading market players to drive sales. It also offers insights across key segments including drug class, distribution channels and route of administration for antibacterial drugs
Fact.MR – A Market Research and Competitive Intelligence Provider: Over the forecast period (2021-2031), the global antibacterial drugs market is expected to grow at a CAGR of 2.6%, reaching a valuation of over US$ 62 billion by 2031 and surpassing US$ 51 billion by 2025. The market is expected to grow at a CAGR of 1.5% over the next half-decade.
The antibacterial drugs market is expanding rapidly, but the market’s prospects are dimmed by a relatively small development pipeline. However, government efforts in a number of nations, particularly in Europe and North America, are expected to result in an increase in the creation of branded pharmaceuticals.
The Center for Drug Evaluation and Research (CDER) Antibacterial Drug Development Task Force, for example, was established by the US Food and Drug Administration in February 2021 to facilitate the development of new antibacterial medications.
Get Sample Copy With Impact Analysis Of COVID-19 Of Market Report
https://www.factmr.com/connectus/sample?flag=S&rep_id=4340
For the development of new antibacterial drugs, all established and emerging economies are performing various research and development initiatives. The testing of the efficacy and safety of newly produced antibacterial medications has been regulated by governments.
Clinical Trials Transformative Initiative (CTTI), for example, has developed approaches for streamlining antibacterial drug development that will aid in the design of clinical trials that will better assess the efficacy and safety of new antibacterial drugs and inform clinical trial planning, recruitment, enrollment, and feasibility.
Due to highly structured health-care industry, rising prevalence of infectious diseases, and launch of novel products, North America is expected to lead the global market throughout the projection period.
“Ongoing research & development to discover potential formulations for addressing the ever growing antibiotic resistance amongst patients is expected to keep growth prospects for antibacterial drugs moderate,” says the Fact.MR analyst.
Key Takeaways:
- Demand for β-lactams is expected to expand fastest, registering a 2% value CAGR.
- Until 2031, drugstores and retail pharmacies will account for 2/5 of global revenues.
- Patients’ proclivity for enteral drugs is projected to increase, on account of oral therapy and relatively safe use than the parenteral route of administration.
- North America is expected to account for 33% of worldwide demand for antibacterial medicines.
- Asia will emerge as the leading market, accounting 50% of the global antibacterial drugs demand.
- During the forecast period, Europe would hold a 35% market share for antibacterial medications.
Growth Drivers:
- On-set of Covid-19 pandemic has resulted in pharmaceutical companies to shift their focus towards developing effective anti-viral vaccinations and drugs.
- Rising geriatric population and demand for efficient and affordable antibacterial drugs to propel the antibacterial drugs market growth.
Key Restraints
- High costs associated with development of branded antibacterial drugs will impair growth in certain emerging economies.
To learn more about Antibacterial Drugs Market, you can get in touch with our Analyst at:
https://www.factmr.com/connectus/sample?flag=AE&rep_id=4340
Competitive Landscape
The global antibacterial drugs market is predicted to become more competitive, with companies focused on establishing a competitive advantage and expanding their market share. Manufacturers can form collaborations with government bodies to obtain financial backing for drug development and, as a result, establish themselves as global market leaders.
- In September 2021, Myovant Sciences and Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) accepted for review a supplemental New Drug Application (sNDA) for MYFEMBREE® (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg) for the management of moderate to severe pain associated with endometriosis.
- In July 2021, AstraZeneca announced that it has entered into a partnership with Regeneron to research, develop and commercialize small molecule compounds directed against the GPR75 target with the potential to treat obesity and related co-morbidities.
Prominent players in the Global Antibacterial Drugs Market are:
- Bayer AG
- Pfizer Inc.
- Sanofi
- GlaxoSmithKline plc.
- Merck & Co., Inc.
- AstraZeneca
- Johnson & Johnson Services Inc.
- Bristol-Myers Squibb Company
- Novartis AG
- Allergan Plc.
More Valuable Insights on Antibacterial Drugs Market
Fact.MR provides an unbiased analysis of the antibacterial drugs market, presenting historical demand data (2016-2020) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the global antibacterial drugs market with a detailed segmentation on the basis of:
- Drug Class
- β-lactam Antibacterial Drugs
- Quinolone Antibacterial Drugs
- Macrolide Antibacterial Drugs
- Tetracycline Antibacterial Drugs
- Aminoglycoside Antibacterial Drugs
- Sulfonamide Antibacterial Drugs
- Phenicols Antibacterial Drugs
- Other Antibacterial Drugs
- Route of Administration
- Enteral Antibacterial Drug Administration
- Parenteral Antibacterial Drug Administration
- Other Antibacterial Drug Administration Routes (Inhalation, Topical, etc.)
- Distribution Channel
- Antibacterial Drug Sales via Hospital Pharmacies
- Antibacterial Drug Sales via Drug Stores and Retail Pharmacies
- Online Antibacterial Drug Sales
Key Questions Covered in the Antibacterial Drugs Market Report
- The report offers insight into antibacterial drugs demand outlook for 2021-2031
- The market study also highlights projected sales growth for antibacterial drugs market between 2021 and 2031
- Antibacterial drugs market survey identifies key growth drivers, restraints, and other forces impacting prevailing trends and evaluation of current market size and forecast and technological advancements within the industry
- Antibacterial drugs market share analysis of the key companies within the industry and coverage of strategies such as mergers & acquisitions, joint ventures, collaborations or partnerships, and others
Explore Fact.MR’s Coverage on the Healthcare Domain –
Parenteral Drug Market Analysis - The increased frequency of chronic illnesses such as cancer, cardiovascular disease, and diabetes has been the primary revenue driver for parenteral drugs around the world, and this trend is unlikely to change very soon.
Self-Administered Medication Market Scope - The self-administered medication market players are focusing on developing drugs and vaccinations that can be used for treatment at home in response to rising demand for self-treatment and healthcare management.
OTC Analgesics Market Forecast - With the wide availability of drugs for relieving various types of pain in distribution stores, OTC analgesic drugs are typically purchased in large quantities. These factors are expected to have an impact on the global OTC analgesics market’s growth.
Geriatric Medicines Market Insights - Continuous research is contributing to the development of innovative drugs, which is positively impacting the geriatric medicine industry’s sales. In the forecast term, the geriatric medicines market is expected to gain traction due to the increasing prevalence of high-quality geriatric care management systems.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to chemical and materials, technology to even the most niche categories. 80% of Fortune 1000’s trust us in critical decision making.
MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
You can access all our chemical and materials research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access, widest coverage on emerging markets, nascent products, and disruptive technologies.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com